KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned (2016 - 2023)

Supernus Pharmaceuticals (SUPN) has disclosed Times Interest Earned for 13 consecutive years, with -$19.33 as the latest value for Q2 2023.

  • Quarterly Times Interest Earned fell 408.31% to -$19.33 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$14.94 through Mar 2024, down 300.91% year-over-year, with the annual reading at -$2.18 for FY2023, 133.44% down from the prior year.
  • Times Interest Earned for Q2 2023 was -$19.33 at Supernus Pharmaceuticals, down from $3.44 in the prior quarter.
  • The five-year high for Times Interest Earned was $21.54 in Q4 2022, with the low at -$19.33 in Q2 2023.
  • Average Times Interest Earned over 5 years is $4.58, with a median of $5.87 recorded in 2021.
  • The sharpest move saw Times Interest Earned soared 1996.02% in 2022, then crashed 408.31% in 2023.
  • Over 5 years, Times Interest Earned stood at $7.07 in 2019, then dropped by 0.17% to $7.05 in 2020, then plummeted by 85.43% to $1.03 in 2021, then skyrocketed by 1996.02% to $21.54 in 2022, then crashed by 189.73% to -$19.33 in 2023.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$19.33, $3.44, and $21.54 for Q2 2023, Q1 2023, and Q4 2022 respectively.